A neurotechnology company has announced it achieved real-time speech and text communication with its Connexus brain-computer interface (BCI) implanted device. In a Sept. 14 announcement, Paradromics, based in Austin, Texas, said the successful communication “was achieved as part of the Connect-One Early Feasibility Study, conducted under an FDA-approved Investigational Device Exemption. Moving beyond researcher-selected copy…